With sales of its respiratory drugs doing well, GlaxoSmithKline has been spending hundreds of millions of dollars to expand manufacturing of several kinds of inhalers. But a glitch at one of its ...
GlaxoSmithKline has added three more lots of its Ventolin inhalers to its recent recall, bringing the total to more than 1.1 million units. According to a recent FDA Enforcement Report, the drugmaker ...
Hundreds of thousands of Facebook users in February 2018 shared an article warning that the pharmaceutical company GlaxoSmithKline had issued a massive recall of Ventolin inhalers, an essential ...
In both the Easyhaler DPI and Evohaler pMDI cohorts, 98.3% of patients with asthma recovered FEV1 to at least -10% of baseline after their last treatment post MC test. Investigators sought to ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Do not take if you have ever had an allergic reaction to VENTOLIN ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Do not use if you have ever had an allergic reaction to VENTOLIN or ...
ASTHMA sufferers have been told to check their inhalers after two brands have issued an urgent recall. Here’s what you need to know to work out if you need to pass your puffer back. Two brands have ...
Albuterol 90mcg/inh; metered-dose aerosol; contains hydrofluoroalkane; CFC-free. The pharmacological effects of beta 2-adrenoceptor agonist drugs are at least in part attributable to stimulation of ...
Purpose: The effects of extreme temperatures on drug delivery of two albuterol sulfate hydrofluoroalkane, metered-dose inhalers (MDIs) were evaluated.Methods. Three Proventil HFA and three Ventolin ...
GSK plc (LSE/NYSE:GSK) announced Wednesday that its next-generation low carbon version of the Ventolin (salbutamol) metered dose inhaler (MDI) achieved positive results in pivotal phase III clinical ...
Simply sign up to the Pharmaceuticals sector myFT Digest -- delivered directly to your inbox. Pharmaceutical groups GSK and AstraZeneca are vying to be the first to finally upgrade their popular ...